Cargando…
High serum levels of soluble CD44 variant isoform v5 are associated with favourable clinical outcome in ovarian cancer.
In 96 ovarian cancer patients, the present study investigates the clinical significance of pretreatment concentrations of soluble CD44 standard (CD44s) and its isoforms v5 and v6 determined in the serum and the ascitic fluid by means of recently developed enzyme-linked immunosorbent assays (ELISAs)....
Autores principales: | Zeimet, A. G., Widschwendter, M., Uhl-Steidl, M., Müller-Holzner, E., Daxenbichler, G., Marth, C., Dapunt, O. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228203/ https://www.ncbi.nlm.nih.gov/pubmed/9413956 |
Ejemplares similares
-
Cisplatin resistance is associated with reduced interferon-gamma-sensitivity and increased HER-2 expression in cultured ovarian carcinoma cells.
por: Marth, C., et al.
Publicado: (1997) -
Retinoic acid modulates prolactin receptor expression and prolactin-induced STAT-5 activation in breast cancer cells in vitro
por: Widschwendter, M, et al.
Publicado: (1999) -
Expression and modulation of CD44 variant isoforms in humans
Publicado: (1994) -
CD44 Variant Isoform Expression and Breast Cancer Prognosis
por: Tokue, Yutaka, et al.
Publicado: (1998) -
Expression of CD44 Variant Isoforms in Normal and Neoplastic Cells of the Lung
por: Washimi, Osuke, et al.
Publicado: (1994)